University College London, Institute of Structural and Molecular Biology, Gower Street, London WC1E 6BT, UK.
Expert Opin Drug Metab Toxicol. 2010 Sep;6(9):1083-94. doi: 10.1517/17425255.2010.503705.
Flavin-containing monooxygenases (FMOs) metabolize a number of therapeutic drugs. However, their role in drug metabolism has been overlooked compared with that of the cytochromes P450 (CYPs). Genetic variants of FMOs are expected to influence drug response and/or contribute to adverse drug reactions.
We review tissue-specific expression of FMOs and genetic variation that may influence drug metabolism. We discuss how the use of mouse lines in which Fmo genes have been deleted can demonstrate the role an FMO plays in the metabolism of a drug, particularly if the drug is subject to metabolism by other enzymes, for example, CYPs, or undergoes retro-reduction. We cite seminal papers and review articles to give the reader an appreciation of the FMO field.
Insights into the problems associated with determining the contribution of an FMO to the metabolism of a drug and how an Fmo-knockout mouse line has revealed the role of FMO1 in the metabolism of imipramine in vivo.
The use of an Fmo-knockout mouse line demonstrates a more important role for FMOs in multi-pathway drug metabolism than has previously been appreciated.
黄素单加氧酶(FMOs)代谢许多治疗药物。然而,与细胞色素 P450(CYPs)相比,它们在药物代谢中的作用被忽视了。FMOs 的遗传变异预计会影响药物反应和/或导致药物不良反应。
我们回顾了 FMO 的组织特异性表达和可能影响药物代谢的遗传变异。我们讨论了使用 Fmo 基因缺失的小鼠品系如何证明 FMO 在药物代谢中的作用,特别是如果药物受到其他酶(例如 CYP)的代谢或发生逆向还原。我们引用了开创性的论文和综述文章,让读者了解 FMO 领域。
深入了解确定 FMO 对药物代谢贡献的相关问题,以及 Fmo 基因敲除小鼠品系如何揭示 FMO1 在体内代谢丙咪嗪中的作用。
使用 Fmo 基因敲除小鼠品系表明,FMOs 在多途径药物代谢中的作用比以前认为的更为重要。